1. Home
  2. SCLXW vs ABVEW Comparison

SCLXW vs ABVEW Comparison

Compare SCLXW & ABVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLXW
  • ABVEW
  • Stock Information
  • Founded
  • SCLXW N/A
  • ABVEW N/A
  • Country
  • SCLXW United States
  • ABVEW Canada
  • Employees
  • SCLXW 31
  • ABVEW N/A
  • Industry
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • ABVEW Packaged Foods
  • Sector
  • SCLXW Health Care
  • ABVEW Consumer Staples
  • Exchange
  • SCLXW Nasdaq
  • ABVEW Nasdaq
  • Market Cap
  • SCLXW N/A
  • ABVEW N/A
  • IPO Year
  • SCLXW N/A
  • ABVEW N/A
  • Fundamental
  • Price
  • SCLXW $0.14
  • ABVEW $0.69
  • Analyst Decision
  • SCLXW
  • ABVEW
  • Analyst Count
  • SCLXW 0
  • ABVEW 0
  • Target Price
  • SCLXW N/A
  • ABVEW N/A
  • AVG Volume (30 Days)
  • SCLXW 4.0K
  • ABVEW N/A
  • Earning Date
  • SCLXW 03-07-2025
  • ABVEW N/A
  • Dividend Yield
  • SCLXW N/A
  • ABVEW N/A
  • EPS Growth
  • SCLXW N/A
  • ABVEW N/A
  • EPS
  • SCLXW N/A
  • ABVEW N/A
  • Revenue
  • SCLXW $55,152,000.00
  • ABVEW N/A
  • Revenue This Year
  • SCLXW N/A
  • ABVEW N/A
  • Revenue Next Year
  • SCLXW N/A
  • ABVEW N/A
  • P/E Ratio
  • SCLXW N/A
  • ABVEW N/A
  • Revenue Growth
  • SCLXW 22.02
  • ABVEW N/A
  • 52 Week Low
  • SCLXW $0.18
  • ABVEW N/A
  • 52 Week High
  • SCLXW $0.18
  • ABVEW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SCLXW 33.86
  • ABVEW 67.31
  • Support Level
  • SCLXW $0.14
  • ABVEW $0.24
  • Resistance Level
  • SCLXW $0.25
  • ABVEW $1.10
  • Average True Range (ATR)
  • SCLXW 0.05
  • ABVEW 0.13
  • MACD
  • SCLXW -0.01
  • ABVEW 0.06
  • Stochastic Oscillator
  • SCLXW 10.79
  • ABVEW 54.91

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About ABVEW Above Food Ingredients Inc. Warrants

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: